That is, R132H mutation, which disrupts normal function of isocitrate dehydrogenase IDH1, negatively affects the growth of glioma progenitor cells, but genetically induced expression of human GLUD2 but not GLUD1 rescues the cells. The gene discussed is GLUD2; the disease is central nervous system cancer.